Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;40(11):680-685.
doi: 10.1055/s-0038-1675807. Epub 2018 Nov 28.

Methotrexate Therapy for Ectopic Pregnancies: A Tertiary Center Experience

Ozgur Ozyuncu  1 , Atakan Tanacan  1 , Sinem Ayse Duru  1 , Mehmet Sinan Beksac  1
Affiliations

Methotrexate Therapy for Ectopic Pregnancies: A Tertiary Center Experience

Ozgur Ozyuncu et al. Rev Bras Ginecol Obstet. 2018 Nov.

Abstract

Objective: Our aim is to demonstrate the importance of methotrexate (MTX) therapy for the treatment of ectopic pregnancy (EP).

Methods: This retrospective study consisted of 99 patients (72 tubal EPs, 20 pregnancies of unknown location (PUL), 4 cesarean section (CS) scar EPs and 3 cervical EPs) treated with MTX.

Results: Methotrexate therapy was successful in 68.5% of EPs. There were statistically significant differences between the MTX success and failure groups based on ultrasonographic findings, patient complaints, gestational week and serum human chorionic gonadotropin (hCG) values. The MTX success rates in PUL and tubal pregnancies were 95% and 61.1%, respectively. The MTX success rates in single-dose, two-dose and multi-dose protocol groups were 86.9%, 28.6% and 40%, respectively. All cervical and CS scar ectopic pregnancies were treated successfully with MTX therapy.

Conclusion: Methotrexate might be the first-line treatment option for EPs under certain conditions. Physicians must be more cautious in cases with higher hCG values, the presence of abdominal-pelvic pain, the presence of fetal cardiac activity, larger gestational sac (GS) diameters, and more advanced gestational weeks according to the last menstrual period.

PubMed Disclaimer

Conflict of interest statement

All authors state that they have no conflict of interest in this study.

References

    1. Marion L L, Meeks G R.Ectopic pregnancy: History, incidence, epidemiology, and risk factors Clin Obstet Gynecol 20125502376–386. Doi: 10.1097/GRF.0b013e3182516d7b - PubMed
    1. Khan K S, Wojdyla D, Say L, Gülmezoglu A M, Van Look P F.WHO analysis of causes of maternal death: a systematic review Lancet 2006367(9516):1066–1074. Doi: 10.1016/S0140-6736(06)68397-9 - PubMed
    1. Helmy S, Koch M, Kölbl H, Grohmann-Izay B, Solomayer E, Bader Y.Correlation of the volume of ectopic pregnancy and MTX therapy outcome: a retrospective cohort study Eur J Obstet Gynecol Reprod Biol 2015184108–111. Doi: 10.1016/j.ejogrb.2014.09.038 - PubMed
    1. Bouyer J, Coste J, Fernandez H, Pouly J L, Job-Spira N.Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases Hum Reprod 200217123224–3230. Doi: 10.1093/humrep/17.12.3224 - PubMed
    1. Alkatout I, Honemeyer U, Strauss Aet al.Clinical diagnosis and treatment of ectopic pregnancy Obstet Gynecol Surv 20136808571–581. Doi: 10.1097/OGX.0b013e31829cdbeb - PubMed

Substances